A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
Lupeng Ye(Zhejiang University), Sidi Chen(Yale Cancer Center), Hanbing Cao(University of New Haven), Youssef Errami(Yale Cancer Center), Guangchuan Wang(Shandong University), Erting Tang(University of New Haven), Xiaoyun Dai(Yale Cancer Center), Yaying Du(Yale Cancer Center), Ryan D. Chow(Yale University), Jonathan J. Park(Yale Cancer Center), Alexey Bersenev(Children's Hospital of Philadelphia), Jianjian Guo(Yale Cancer Center), Hyunu R. Kim(Yale Cancer Center), Quanjun Yang(Yale Cancer Center), Stanley Z. Lam(Yale Cancer Center), Matthew B. Dong(Yale University), Yueqi Zhang(Capital Medical University), Paul Clark(Yale University), Lei Peng(Yale Cancer Center), Ruth R. Montgomery(Fred Hutch Cancer Center)
Cited by 190
Related Papers
High-content CRISPR screening
|Nature Reviews Methods Primers|2022|572
New genes as drivers of phenotypic evolution
|Nature Reviews Genetics|2013|441